Resultados da busca - Jessen, Heiko
- Mostrando 1 - 20 resultados de 47
- Ir para a próxima página
-
1
-
2
Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic por Marin-Webb, Victor, Jessen, Heiko, Kopp, Ute, Jessen, Arne B., Hahn, Katrin
Publicado em 2016Texto -
3
-
4
Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study por Koppe, Uwe, Marcus, Ulrich, Albrecht, Stefan, Jansen, Klaus, Jessen, Heiko, Gunsenheimer‐Bartmeyer, Barbara, Bremer, Viviane
Publicado em 2019Texto -
5
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany por Koppe, Uwe, Marcus, Ulrich, Albrecht, Stefan, Jansen, Klaus, Jessen, Heiko, Gunsenheimer-Bartmeyer, Barbara, Bremer, Viviane
Publicado em 2021Texto -
6
HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019 por Koppe, Uwe, Seifried, Janna, Marcus, Ulrich, Albrecht, Stefan, Jansen, Klaus, Jessen, Heiko, Gunsenheimer-Bartmeyer, Barbara, Bremer, Viviane
Publicado em 2022Texto -
7
Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort por Machnowska, Patrycja, Meixenberger, Karolin, Schmidt, Daniel, Jessen, Heiko, Hillenbrand, Heribert, Gunsenheimer-Bartmeyer, Barbara, Hamouda, Osamah, Kücherer, Claudia, Bannert, Norbert
Publicado em 2019Texto -
8
Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort por Bartmeyer, Barbara, Kuecherer, Claudia, Houareau, Claudia, Werning, Johanna, Keeren, Kathrin, Somogyi, Sybille, Kollan, Christian, Jessen, Heiko, Dupke, Stephan, Hamouda, Osamah
Publicado em 2010Texto -
9
STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany por Jansen, Klaus, Steffen, Gyde, Potthoff, Anja, Schuppe, Ann-Kathrin, Beer, Daniel, Jessen, Heiko, Scholten, Stefan, Spornraft-Ragaller, Petra, Bremer, Viviane, Tiemann, Carsten
Publicado em 2020Texto -
10
First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Stu... por zu Knyphausen, Fabia, Scheufele, Ramona, Kücherer, Claudia, Jansen, Klaus, Somogyi, Sybille, Dupke, Stephan, Jessen, Heiko, Schürmann, Dirk, Hamouda, Osamah, Meixenberger, Karolin, Bartmeyer, Barbara
Publicado em 2014Texto -
11
CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual por Oh, Djin-Ye, Jessen, Heiko, Kücherer, Claudia, Neumann, Konrad, Oh, Nari, Poggensee, Gabriele, Bartmeyer, Barbara, Jessen, Arne, Pruss, Axel, Schumann, Ralf R., Hamouda, Osamah
Publicado em 2008Texto -
12
Nevirapine Significantly Reduces the Levels of Racemic Methadone and (R)-Methadone in Human Immunodeficiency Virus-Infected Patients por Stocker, Hartmut, Kruse, Guido, Kreckel, Peter, Herzmann, Christian, Arastéh, Keikawus, Claus, Jörg, Jessen, Heiko, Cordes, Christiane, Hintsche, Bettina, Schlote, Frank, Schneider, Lothar, Kurowski, Michael
Publicado em 2004Texto -
13
Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors por Toyoda, Mako, Ogata, Yoko, Mahiti, Macdonald, Maeda, Yosuke, Kuang, Xiaomei T., Miura, Toshiyuki, Jessen, Heiko, Walker, Bruce D., Brockman, Mark A., Brumme, Zabrina L., Ueno, Takamasa
Publicado em 2015Texto -
14
Epidemiologically-Linked Transmission of HIV-1 Illustrates the Impact of Host Genetics on Virological Outcome por Streeck, Hendrik, Jessen, Heiko, Kücherer, Claudia, Li, Bin, Jessen, Arne B., Dupke, Stephan, Baumgarten, Axel, Stahmer, Ingrid, van Lunzen, Jan, Altfeld, Marcus, Walker, Bruce D., Allen, Todd M.
Publicado em 2009Texto -
15
Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin – A multicentre, cross-sectional survey por Werner, Ricardo Niklas, Gaskins, Matthew, Ahrens, Jens, Jessen, Heiko, Kutscha, Frank, Mosdzen, Regina, Osswald, Wolfgang, Sander, Dirk, Schellberg, Sven, Schwabe, Kai, Wünsche, Thomas, Dressler, Corinna, Sammons, Mary, Nast, Alexander
Publicado em 2018Texto -
16
Anti-APOBEC3G Activity of HIV-1 Vif Protein Is Attenuated in Elite Controllers por Kikuchi, Tadashi, Iwabu, Yukie, Tada, Takuya, Kawana-Tachikawa, Ai, Koga, Michiko, Hosoya, Noriaki, Nomura, Shigeru, Brumme, Zabrina L., Jessen, Heiko, Pereyra, Florencia, Trocha, Alicja, Walker, Bruce D., Iwamoto, Aikichi, Tokunaga, Kenzo, Miura, Toshiyuki
Publicado em 2015Texto -
17
Induction of Gag-Specific CD4 T Cell Responses during Acute HIV Infection Is Associated with Improved Viral Control por Schieffer, Miriam, Jessen, Heiko K., Oster, Alexander F., Pissani, Franco, Soghoian, Damien Z., Lu, Richard, Jessen, Arne B., Zedlack, Carmen, Schultz, Bruce T., Davis, Isaiah, Ranasinghe, Srinika, Rosenberg, Eric S., Alter, Galit, Schumann, Ralf R., Streeck, Hendrik
Publicado em 2014Texto -
18
Emergence of Individual HIV-Specific CD8 T Cell Responses during Primary HIV-1 Infection Can Determine Long-Term Disease Outcome por Streeck, Hendrik, Lu, Richard, Beckwith, Noor, Milazzo, Mark, Liu, Michelle, Routy, Jean-Pierre, Little, Susan, Jessen, Heiko, Kelleher, Anthony D., Hecht, Frederick, Sekaly, Rafick-Pierre, Alter, Galit, Heckerman, David, Carrington, Mary, Rosenberg, Eric S., Altfeld, Marcus
Publicado em 2014Texto -
19
A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review por Cox, Joseph, Gutner, Cassidy, Kronfli, Nadine, Lawson, Anna, Robbins, Michele, Nientker, Lisette, Ostawal, Amrita, Barber, Tristan, Croce, Davide, Hardy, David, Jessen, Heiko, Katlama, Christine, Mallolas, Josep, Rizzardini, Giuliano, Alcorn, Keith, Wohlfeiler, Michael, Le Fevre, Eric
Publicado em 2019Texto -
20
Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults por Moreira, Edson D, Palefsky, Joel M, Giuliano, Anna R, Goldstone, Stephen, Aranda, Carlos, Jessen, Heiko, Hillman, Richard J, Ferris, Daron, Coutlee, Francois, Vardas, Eftyhia, Marshall, J Brooke, Vuocolo, Scott, Haupt, Richard M, Guris, Dalya, Garner, Elizabeth IO
Publicado em 2011Texto